The efficacy of anti-TNF in rheumatoid arthritis, a comparison between randomised controlled trials and clinical practice. [electronic resource]
Producer: 20071109Description: 1473-8 p. digitalISSN:- 0003-4967
- Adalimumab
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Antirheumatic Agents -- therapeutic use
- Arthritis, Rheumatoid -- drug therapy
- Etanercept
- Female
- Humans
- Immunoglobulin G -- therapeutic use
- Immunologic Factors -- therapeutic use
- Infliximab
- Male
- Middle Aged
- Netherlands
- Patient Selection
- Product Surveillance, Postmarketing
- Randomized Controlled Trials as Topic
- Receptors, Tumor Necrosis Factor -- therapeutic use
- Registries
- Research Design
- Severity of Illness Index
- Treatment Outcome
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Review; Systematic Review
There are no comments on this title.
Log in to your account to post a comment.